David C. Warltier spends much of his time researching Anesthesia, Internal medicine, Isoflurane, Cardiology and Hemodynamics. His work deals with themes such as Adenosine, Pharmacology, Ischemia and Perfusion, which intersect with Anesthesia. His work focuses on many connections between Internal medicine and other disciplines, such as Endocrinology, that overlap with his field of interest in Neovascularization and Angiogenesis.
His Isoflurane research is multidisciplinary, relying on both Cardioprotection, Halothane and Anesthetic. His studies examine the connections between Cardiology and genetics, as well as such issues in Arterial blood, with regards to Hydroxyethyl starch, Orthopedic surgery and Hetastarch. His Hemodynamics research is multidisciplinary, incorporating elements of Contractility, Fissipedia and Blood pressure.
His primary scientific interests are in Internal medicine, Anesthesia, Cardiology, Hemodynamics and Isoflurane. His research on Internal medicine frequently links to adjacent areas such as Endocrinology. His research on Anesthesia often connects related topics like Contractility.
The concepts of his Cardiology study are interwoven with issues in Diastole and Heart rate. His work is dedicated to discovering how Hemodynamics, Nifedipine are connected with Dihydropyridine and other disciplines. His Isoflurane research incorporates elements of Anesthetic, Halothane and Pharmacology.
The scientist’s investigation covers issues in Cardioprotection, Anesthesia, Internal medicine, Isoflurane and Pharmacology. His Cardioprotection research integrates issues from Reperfusion injury, Anesthetic, Biochemistry and Ischemic preconditioning. His Anesthesia study integrates concerns from other disciplines, such as Orthopedic surgery, Cardiac surgery and Hypoxia reoxygenation.
His Internal medicine study incorporates themes from Diabetes mellitus, Endocrinology and Cardiology. His work on Circulatory system as part of general Cardiology study is frequently linked to Collateralization, therefore connecting diverse disciplines of science. His work in the fields of Isoflurane, such as Minimum alveolar concentration, overlaps with other areas such as In vivo.
David C. Warltier mostly deals with Anesthesia, Isoflurane, Cardioprotection, In vivo and Biochemistry. His studies in Anesthesia integrate themes in fields like Cardiac surgery, Complication and Coronary occlusion. He interconnects Endocrinology, Wortmannin and Pharmacology in the investigation of issues within Isoflurane.
His Cardioprotection research is multidisciplinary, incorporating perspectives in Anesthetic and Nitric oxide. His Anesthetic study combines topics in areas such as Ischemia and Ischemic preconditioning. His work in Ischemic preconditioning tackles topics such as Receptor which are related to areas like Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.
Judy R. Kersten;Todd J. Schmeling;Paul S. Pagel;Garrett J. Gross.
Anesthesiology (1997)
Isoflurane Protects against Myocardial Infarction during Early Reperfusion by Activation of Phosphatidylinositol-3-Kinase Signal Transduction: Evidence for Anesthetic-induced Postconditioning in Rabbits
Pascal C. Chiari;Martin W. Bienengraeber;Paul S. Pagel;John G. Krolikowski.
Anesthesiology (2005)
Mechanisms of cardioprotection by volatile anesthetics.
Katsuya Tanaka;Lynda M. Ludwig;Judy R. Kersten;Paul S. Pagel.
Anesthesiology (2004)
Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels.
Judy R. Kersten;Matthew W. Montgomery;Paul S. Pagel;David C. Warltier.
Anesthesia & Analgesia (2000)
Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane.
David C. Warltier;Mahmood H. Al-Wathiqui;John P. Kampine;William T. Schmeling.
Anesthesiology (1988)
Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality
Judy R. Kersten;Wolfgang G. Toller;Eric R. Gross;Paul S. Pagel.
American Journal of Physiology-heart and Circulatory Physiology (2000)
Acute hyperglycemia abolishes ischemic preconditioning in vivo
Judy R. Kersten;Todd J. Schmeling;Karl G. Orth;Paul S. Pagel.
American Journal of Physiology-heart and Circulatory Physiology (1998)
Ketamine Attenuates Delirium After Cardiac Surgery With Cardiopulmonary Bypass
Judith A. Hudetz;Kathleen M. Patterson;Zafar Iqbal;Sweeta D. Gandhi.
Journal of Cardiothoracic and Vascular Anesthesia (2009)
Ischemia-Induced Coronary Collateral Growth Is Dependent on Vascular Endothelial Growth Factor and Nitric Oxide
Toshiro Matsunaga;David C. Warltier;Dorothee W. Weihrauch;Melinda Moniz.
Circulation (2000)
Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs.
G. J. Gross;N. E. Farber;H. F. Hardman;D. C. Warltier.
American Journal of Physiology-heart and Circulatory Physiology (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Medical College of Wisconsin
Medical College of Wisconsin
Medical College of Wisconsin
Northeast Ohio Medical University
Boston Children's Hospital
University of Illinois at Urbana-Champaign
Medical College of Wisconsin
University of Michigan–Ann Arbor
Medical College of Wisconsin
Medical College of Wisconsin
Wuhan University
Institute of Photonic Sciences
University of Strasbourg
Bharathiar University
University College London
University of Turin
Johns Hopkins University
University of Naples Federico II
Columbia University
Newcastle University
Scripps Health
University of Copenhagen
University of Leon
MIT
New York University
University of British Columbia